SCYNEXIS, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
SCYNEXIS, Inc. (SCYX) reported Stock Issued During Period, Shares, Reverse Stock Splits of 0 shares for the 0-month period ending 2020-07-17, per its 10-K filed 2022-03-29.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2022-03-29
- 2020-07-17: Stock Issued During Period, Shares, Reverse Stock Splits 0 month 0.00 shares; Stock Issued During Period, Shares, Reverse Stock Splits 0.00 shares.
- 2020-07-16: Stock Issued During Period, Shares, Reverse Stock Splits 0 month 0.00 shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits 0 month | Stock Issued During Period, Shares, Reverse Stock Splits |
|---|---|---|
| 2020-07-17 | 0.00 shares 10-K · filed 2022-03-29 | 0.00 shares 10-Q · filed 2020-11-06 |
| 2020-07-16 | 0.00 shares 10-Q · filed 2020-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |